Literature DB >> 11747897

Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes.

A Molina-Hernández1, A Nuñez, J J Sierra, J A Arias-Montaño.   

Abstract

The release of glutamate from striatal synaptosomes induced by depolarisation with 4-aminopyridine (4-AP) was studied by a method based on the fluorescent properties of the NAPDH formed by the metabolism of the neurotransmitter by glutamate dehydrogenase.Ca(2+)-dependent, depolarisation-induced glutamate release was inhibited in a concentration-dependent manner by the selective histamine H(3) agonist immepip. Best-fit estimates were: maximum inhibition 60+/-10% and IC(50) 68+/-10 nM. The effect of 300 nM immepip on depolarisation-evoked glutamate release was reversed by the selective H(3) antagonist thioperamide in a concentration-dependent manner (EC(50) 23 nM, K(i) 4 nM). In fura-2-loaded synaptosomes, the increase in the intracellular concentration of Ca(2+) ([Ca(2+)](i)) evoked by 4-AP-induced depolarisation (resting level 167+/-14 nM; Delta[Ca(2+)](i) 88+/-15 nM) was modestly, but significantly reduced (29+/-5% inhibition) by 300 nM immepip. The action of the H(3) agonist on depolarisation-induced changes in [Ca(2+)](i) was reversed by 100 nM thioperamide. Taken together, our results indicate that histamine modulates the release of glutamate from corticostriatal nerve terminals. Inhibition of depolarisation-induced Ca(2+) entry through voltage-dependent Ca(2+) channels appears to account for the effect of H(3) receptor activation on neurotransmitter release. Modulation of glutamatergic transmission in rat striatum may have important consequences for the function of basal ganglia and therefore for the control of motor behaviour.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747897     DOI: 10.1016/s0028-3908(01)00144-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  22 in total

1.  Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function.

Authors:  Carla Ferrada; Sergi Ferré; Vicent Casadó; Antonio Cortés; Zuzana Justinova; Chanel Barnes; Enric I Canela; Steven R Goldberg; Rob Leurs; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

2.  New insights into the organization of the basal ganglia.

Authors:  James B Koprich; Tom H Johnston; Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

Review 3.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

4.  Effects of a novel cognition-enhancing agent on fetal ethanol-induced learning deficits.

Authors:  Daniel D Savage; Martina J Rosenberg; Christina R Wolff; Katherine G Akers; Ahmed El-Emawy; Miranda C Staples; Rafael K Varaschin; Carrie A Wright; Jessica L Seidel; Kevin K Caldwell; Derek A Hamilton
Journal:  Alcohol Clin Exp Res       Date:  2010-07-09       Impact factor: 3.455

5.  Histaminergic Control of Corticostriatal Synaptic Plasticity during Early Postnatal Development.

Authors:  Sungwon Han; Ricardo Márquez-Gómez; Myles Woodman; Tommas Ellender
Journal:  J Neurosci       Date:  2020-07-24       Impact factor: 6.167

6.  Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively.

Authors:  Keri E Cannon; Rob Leurs; Lindsay B Hough
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

7.  Differential effects of the histamine H(3) receptor agonist methimepip on dentate granule cell excitability, paired-pulse plasticity and long-term potentiation in prenatal alcohol-exposed rats.

Authors:  Rafael K Varaschin; Martina J Rosenberg; Derek A Hamilton; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2014-05-12       Impact factor: 3.455

8.  Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Authors:  Catherine Pillot; Jordi Ortiz; Anne Héron; Sophie Ridray; Jean-Charles Schwartz; Jean-Michel Arrang
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

9.  The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.

Authors:  John A Gruner; Val R Marcy; Yin-Guo Lin; Donna Bozyczko-Coyne; Michael J Marino; Maciej Gasior
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

10.  Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata.

Authors:  Sarah Threlfell; Stephanie J Cragg; Imre Kalló; Gergely F Turi; Clive W Coen; Susan A Greenfield
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.